InsidersTradesSigma
Browse the full record of transactions filed by Ashman Philip, Chief Executive Officer. Officer active across 1 companies, notably Alimera Sciences INC. In total, 4 reports have been published. The latest transaction was filed on 10 January 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
4 of 4 declarations
Philip Ashman is Chief Operating Officer and SVP at Alimera Sciences Inc. He oversees the company's operations, which specializes in developing ophthalmic treatments. Philip uses his expertise to enhance operational efficiency and the company's strategy.